These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 6227373)

  • 1. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL; Krstich M; Beart PM
    Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
    De Vries DJ; Beart PM
    Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW; Leff SE; Creese I
    Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical studies of the mesolimbic dopaminergic pathway: [3H]spiperone labels two bindings sites in homogenates of the nucleus accumbens of rat brain.
    Beart PM; McDonald D
    J Neurochem; 1982 Nov; 39(5):1452-60. PubMed ID: 6126526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
    Sibley DR; Creese I
    Mol Pharmacol; 1983 May; 23(3):585-93. PubMed ID: 6223205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide.
    Grigoriadis D; Seeman P
    J Neurochem; 1985 Jun; 44(6):1925-35. PubMed ID: 3157782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J; Briley M; Langer SZ
    Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL; Largent BL; Snyder SH
    Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptors labelled by [3H]quinpirole.
    Seeman P; Schaus JM
    Eur J Pharmacol; 1991 Oct; 203(1):105-9. PubMed ID: 1686763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.
    Fuxe K; Agnati LF; Köhler C; Kuonen D; Ogren SO; Andersson K; Hökfelt T
    J Neural Transm; 1981; 51(1-2):3-37. PubMed ID: 7264628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
    Leff SE; Hamblin MW; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):171-83. PubMed ID: 3969066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.